Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutation
The complete form of X-linked congenital stationary night blindness (CSNB) is a rare genetic disease caused by a mutation in the NYX gene. CSNB is associated with the mutations taking place in 17 genes, whilst its CSNB1A form is caused by the mutations in the NYX gene, which were characterized earli...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Real Time Ltd
2019-08-01
|
Series: | Российский офтальмологический журнал |
Subjects: | |
Online Access: | https://roj.igb.ru/jour/article/view/304 |
id |
doaj-01aeb942b8a8469a9671f5327953e5ec |
---|---|
record_format |
Article |
spelling |
doaj-01aeb942b8a8469a9671f5327953e5ec2021-07-28T13:01:40ZrusReal Time LtdРоссийский офтальмологический журнал2072-00762587-57602019-08-01123778410.21516/2072-0076-2019-12-3-77-84238Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutationM. E. Ivanova0K. V. Gorgisheli1I. V. Zolnikova2D. S. Atarshchikov3D. Barh4Zh. M. Salmasi5L. M. Balashova6Oftalmic Research and Clinical CenterGenomed Genetic LaboratoryHelmholtz National Medical Research Center of Eye DiseasesCentral Clinical Hospital with Polyclinic, Office of the PresidentCenter for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Biotechnology (IIOAB)N.I. Pirogov Russian National Research Medical UniversityNon-profit partnership International Scientific and Practical Center for the Proliferation of TissuesThe complete form of X-linked congenital stationary night blindness (CSNB) is a rare genetic disease caused by a mutation in the NYX gene. CSNB is associated with the mutations taking place in 17 genes, whilst its CSNB1A form is caused by the mutations in the NYX gene, which were characterized earlier, although nothing had been reported so far about the Russian founder principle. The paper analyzes the pathogenetic mechanisms in a family with diagnosed CSNB1A and a new genetically confirmed mutation in the NYX gene in four members of one Russian family. Two brothers of the four siblings (two boys, two girls) with congenital stationary night blindness, diagnosed in early childhood, and high myopia underwent a standard ophthalmic examination, supplemented with OCT, electroretinography and color blind test with tables by Rabkin and Farnsworth test, whereupon they were sent to molecular genetics confirmation of the diagnosis by whole exome sequencing with subsequent Sanger sequencing confirmation of the detected mutation in the proband and proband’s relatives. In members of the family with clinical features of CSNB1A the reading frame shift mutation was genetically confirmed in the NYX gene (c.283delC, p.His95fs, NM_022567.2). This mutation is inherited in X-linked form. This is the first report of a case with a novel and probable founder mutation from Russia associated with CSNB1A. Since the mRNA of a NYX gene consists of only 2696 base pairs, a gene replacement therapy, or CRISPR-based gene editing, or a similar approach may be envisaged for the correction of frameshift in His95fs position.https://roj.igb.ru/jour/article/view/304csnb1anyxcongenital stationary night blindnessgene therapyleucine-rich domain |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
M. E. Ivanova K. V. Gorgisheli I. V. Zolnikova D. S. Atarshchikov D. Barh Zh. M. Salmasi L. M. Balashova |
spellingShingle |
M. E. Ivanova K. V. Gorgisheli I. V. Zolnikova D. S. Atarshchikov D. Barh Zh. M. Salmasi L. M. Balashova Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutation Российский офтальмологический журнал csnb1a nyx congenital stationary night blindness gene therapy leucine-rich domain |
author_facet |
M. E. Ivanova K. V. Gorgisheli I. V. Zolnikova D. S. Atarshchikov D. Barh Zh. M. Salmasi L. M. Balashova |
author_sort |
M. E. Ivanova |
title |
Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutation |
title_short |
Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutation |
title_full |
Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutation |
title_fullStr |
Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutation |
title_full_unstemmed |
Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutation |
title_sort |
pathogenesis and clinical features of congenital stationary night blindness in case of c.283delc nyx gene mutation |
publisher |
Real Time Ltd |
series |
Российский офтальмологический журнал |
issn |
2072-0076 2587-5760 |
publishDate |
2019-08-01 |
description |
The complete form of X-linked congenital stationary night blindness (CSNB) is a rare genetic disease caused by a mutation in the NYX gene. CSNB is associated with the mutations taking place in 17 genes, whilst its CSNB1A form is caused by the mutations in the NYX gene, which were characterized earlier, although nothing had been reported so far about the Russian founder principle. The paper analyzes the pathogenetic mechanisms in a family with diagnosed CSNB1A and a new genetically confirmed mutation in the NYX gene in four members of one Russian family. Two brothers of the four siblings (two boys, two girls) with congenital stationary night blindness, diagnosed in early childhood, and high myopia underwent a standard ophthalmic examination, supplemented with OCT, electroretinography and color blind test with tables by Rabkin and Farnsworth test, whereupon they were sent to molecular genetics confirmation of the diagnosis by whole exome sequencing with subsequent Sanger sequencing confirmation of the detected mutation in the proband and proband’s relatives. In members of the family with clinical features of CSNB1A the reading frame shift mutation was genetically confirmed in the NYX gene (c.283delC, p.His95fs, NM_022567.2). This mutation is inherited in X-linked form. This is the first report of a case with a novel and probable founder mutation from Russia associated with CSNB1A. Since the mRNA of a NYX gene consists of only 2696 base pairs, a gene replacement therapy, or CRISPR-based gene editing, or a similar approach may be envisaged for the correction of frameshift in His95fs position. |
topic |
csnb1a nyx congenital stationary night blindness gene therapy leucine-rich domain |
url |
https://roj.igb.ru/jour/article/view/304 |
work_keys_str_mv |
AT meivanova pathogenesisandclinicalfeaturesofcongenitalstationarynightblindnessincaseofc283delcnyxgenemutation AT kvgorgisheli pathogenesisandclinicalfeaturesofcongenitalstationarynightblindnessincaseofc283delcnyxgenemutation AT ivzolnikova pathogenesisandclinicalfeaturesofcongenitalstationarynightblindnessincaseofc283delcnyxgenemutation AT dsatarshchikov pathogenesisandclinicalfeaturesofcongenitalstationarynightblindnessincaseofc283delcnyxgenemutation AT dbarh pathogenesisandclinicalfeaturesofcongenitalstationarynightblindnessincaseofc283delcnyxgenemutation AT zhmsalmasi pathogenesisandclinicalfeaturesofcongenitalstationarynightblindnessincaseofc283delcnyxgenemutation AT lmbalashova pathogenesisandclinicalfeaturesofcongenitalstationarynightblindnessincaseofc283delcnyxgenemutation |
_version_ |
1721277162814701568 |